297 related articles for article (PubMed ID: 25241262)
1. Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.
Lafolie J; Nicolas-Chanoine MH; Grenouillet F; Hocquet D; Bertrand X
Int J Antimicrob Agents; 2014 Nov; 44(5):466-8. PubMed ID: 25241262
[TBL] [Abstract][Full Text] [Related]
2. Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
Sauget M; Cholley P; Vannier A; Thouverez M; Nicolas-Chanoine MH; Hocquet D; Bertrand X
Int J Antimicrob Agents; 2016 Dec; 48(6):744-747. PubMed ID: 27836379
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
Colpan A; Johnston B; Porter S; Clabots C; Anway R; Thao L; Kuskowski MA; Tchesnokova V; Sokurenko EV; Johnson JR;
Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
[TBL] [Abstract][Full Text] [Related]
5. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
[TBL] [Abstract][Full Text] [Related]
6. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing
Teramae M; Osawa K; Shigemura K; Kitagawa K; Shirakawa T; Fujisawa M; Miyara T
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635210
[TBL] [Abstract][Full Text] [Related]
8. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
Rogers BA; Ingram PR; Runnegar N; Pitman MC; Freeman JT; Athan E; Havers S; Sidjabat HE; Gunning E; De Almeida M; Styles K; Paterson DL;
Int J Antimicrob Agents; 2015 Apr; 45(4):351-8. PubMed ID: 25707371
[TBL] [Abstract][Full Text] [Related]
9. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.
Kim SY; Park YJ; Johnson JR; Yu JK; Kim YK; Kim YS
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):97-101. PubMed ID: 26643062
[TBL] [Abstract][Full Text] [Related]
11. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
13. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
Madigan T; Johnson JR; Clabots C; Johnston BD; Porter SB; Slater BS; Banerjee R
Clin Infect Dis; 2015 Jul; 61(1):e5-12. PubMed ID: 25828998
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Characteristics of Sequence Type 131
Park JY; Yun KW; Choi EH; Lee HJ
Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
[No Abstract] [Full Text] [Related]
15. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
16. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
Johnston BD; Thuras PD; Johnson JR
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115034. PubMed ID: 32331800
[TBL] [Abstract][Full Text] [Related]
17. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.
Ho PL; Chu YP; Lo WU; Chow KH; Law PY; Tse CW; Ng TK; Cheng VC; Que TL
J Med Microbiol; 2015 Mar; 64(Pt 3):243-247. PubMed ID: 25587081
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
[TBL] [Abstract][Full Text] [Related]
20. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
